Cyclic Peptides for Drug Development
- PMID: 37870189
- DOI: 10.1002/anie.202308251
Cyclic Peptides for Drug Development
Erratum in
-
Corrigendum: Cyclic Peptides for Drug Development.Angew Chem Int Ed Engl. 2024 Mar 4;63(10):e202319807. doi: 10.1002/anie.202319807. Epub 2024 Jan 22. Angew Chem Int Ed Engl. 2024. PMID: 38251885 No abstract available.
Abstract
Cyclic peptides are fascinating molecules abundantly found in nature and exploited as molecular format for drug development as well as other applications, ranging from research tools to food additives. Advances in peptide technologies made over many years through improved methods for synthesis and drug development have resulted in a steady stream of new drugs, with an average of around one cyclic peptide drug approved per year. Powerful technologies for screening random peptide libraries, and de novo generating ligands, have enabled the development of cyclic peptide drugs independent of naturally derived molecules and now offer virtually unlimited development opportunities. In this review, we feature therapeutically relevant cyclic peptides derived from nature and discuss the unique properties of cyclic peptides, the enormous technological advances in peptide ligand development in recent years, and current challenges and opportunities for developing cyclic peptides that address unmet medical needs.
Keywords: Cyclic Peptide; Macrocycle; Peptide; Peptide Drug; Peptide Therapeutics.
© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
References
-
- None
-
- L. Thorstholm, D. J. Craik, Drug Discovery Today Technol. 2012, 9, e13-e21;
-
- K. Bajaj, in Studies in Natural Products Chemistry, Elsevier, Amsterdam, 2019, pp. 343-376.
-
- None
-
- A. Zorzi, K. Deyle, C. Heinis, Curr. Opin. Chem. Biol. 2017, 38, 24-29;
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
